MedPath

EISAI AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

TGA:15

Drug Approvals

DAYVIGO lemborexant 5 mg film coated tablet blister pack (338631)

Product Name
DAYVIGO lemborexant 5 mg film coated tablet blister pack
Approval Date
Jul 16, 2021
TGA

DAYVIGO lemborexant 10 mg film coated tablet blister pack (338645)

Product Name
DAYVIGO lemborexant 10 mg film coated tablet blister pack
Approval Date
Jul 16, 2021
TGA

FYCOMPA perampanel (as hemisesquihydrate) 2 mg/4 mL oral suspension (332505)

Product Name
FYCOMPA perampanel (as hemisesquihydrate) 2 mg/4 mL oral suspension
Approval Date
Feb 16, 2021
TGA

INOVELON rufinamide 200 mg film-coated tablet blister pack (287524)

Product Name
INOVELON rufinamide 200 mg film-coated tablet blister pack
Approval Date
Jun 27, 2018
TGA

INOVELON rufinamide 100 mg film-coated tablet blister pack (287523)

Product Name
INOVELON rufinamide 100 mg film-coated tablet blister pack
Approval Date
Jun 27, 2018
TGA

INOVELON rufinamide 400 mg film-coated tablet blister pack (287537)

Product Name
INOVELON rufinamide 400 mg film-coated tablet blister pack
Approval Date
Jun 27, 2018
TGA

LENVIMA lenvatinib 4mg hard capsule blister pack (233425)

Product Name
LENVIMA lenvatinib 4mg hard capsule blister pack
Approval Date
Jan 28, 2016
TGA

LENVIMA lenvatinib 10mg hard capsule blister pack (233426)

Product Name
LENVIMA lenvatinib 10mg hard capsule blister pack
Approval Date
Jan 28, 2016
TGA

FYCOMPA perampanel (as hemisesquihydrate) 10 mg film coated tablet blister (207692)

Product Name
FYCOMPA perampanel (as hemisesquihydrate) 10 mg film coated tablet blister
Approval Date
May 23, 2014
TGA

FYCOMPA perampanel (as hemisesquihydrate) 6 mg film coated tablet blister (207688)

Product Name
FYCOMPA perampanel (as hemisesquihydrate) 6 mg film coated tablet blister
Approval Date
May 23, 2014
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath